Oramed Pharmaceuticals Stock Price on October 1, 2024
| ORMP Stock | USD 2.37 0.02 0.85% |
Below is the normalized historical share price chart for Oramed Pharmaceuticals extending back to March 19, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oramed Pharmaceuticals stands at 2.37, as last reported on the 30th of November, with the highest price reaching 2.41 and the lowest price hitting 2.36 during the day.
If you're considering investing in Oramed Stock, it is important to understand the factors that can impact its price. Currently, Oramed Pharmaceuticals is relatively risky. Oramed Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 2.0E-4, which implies the firm had a 2.0E-4% return per unit of risk over the last 3 months. We have found thirty technical indicators for Oramed Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Oramed Pharmaceuticals' Coefficient Of Variation of 17497.47, semi deviation of 2.19, and Risk Adjusted Performance of 0.011 to confirm if the risk estimate we provide is consistent with the expected return of 4.0E-4%.
At this time, Oramed Pharmaceuticals' Total Stockholder Equity is relatively stable compared to the past year. As of 11/30/2024, Common Stock Shares Outstanding is likely to grow to about 42.6 M, while Stock Based Compensation is likely to drop slightly above 2.2 M. . At this time, Oramed Pharmaceuticals' Price To Sales Ratio is relatively stable compared to the past year. As of 11/30/2024, Price Earnings Ratio is likely to grow to 17.70, while Price To Free Cash Flows Ratio is likely to drop (9.27). Oramed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of April 2006 | 200 Day MA 2.5269 | 50 Day MA 2.3794 | Beta 1.77 |
Oramed |
Sharpe Ratio = 2.0E-4
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ORMP |
Estimated Market Risk
| 2.34 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Oramed Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oramed Pharmaceuticals by adding Oramed Pharmaceuticals to a well-diversified portfolio.
Price Book 0.6107 | Enterprise Value Ebitda 0.5244 | Price Sales 141.5422 | Shares Float 33.7 M | Wall Street Target Price 3.25 |
Related Headline
Amicus Therapeutics Headline on 1st of October 2024
Disposition of 7500 shares by Campbell Bradley L of Amicus T... by Campbell Bradley L
Filed transaction by Amicus Therapeutics Director, Officer: President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Oramed Pharmaceuticals Valuation on October 1, 2024
It is possible to determine the worth of Oramed Pharmaceuticals on a given historical date. On October 1, 2024 Oramed was worth 2.42 at the beginning of the trading date compared to the closed value of 2.4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oramed Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Oramed Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oramed Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oramed Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 2.47 | 2.54 | 2.44 | 2.44 | 102,940 | |
10/01/2024 | 2.42 | 2.42 | 2.35 | 2.40 | 106,765 |
| 2.40 | 2.42 | 2.36 | 2.39 | 47,227 |
| Backtest Oramed Pharmaceuticals | | | Oramed Pharmaceuticals History | | | Oramed Pharmaceuticals Valuation | Previous | Next |
Oramed Pharmaceuticals Trading Date Momentum on October 1, 2024
| On October 02 2024 Oramed Pharmaceuticals was traded for 2.39 at the closing time. The top price for the day was 2.42 and the lowest listed price was 2.36 . The trading volume for the day was 47.2 K. The trading history from October 2, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.42% . The trading delta at closing time against the current closing price is 0.83% . |
Oramed Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Oramed Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oramed Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oramed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Oramed Pharmaceuticals Stock history
Oramed Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oramed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oramed Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oramed Pharmaceuticals stock prices may prove useful in developing a viable investing in Oramed Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 40.6 M | 42.6 M |
Oramed Pharmaceuticals Quarterly Net Working Capital |
|
Oramed Pharmaceuticals Stock Technical Analysis
Oramed Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Oramed Pharmaceuticals Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Oramed Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Oramed Pharmaceuticals November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Oramed Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oramed Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Oramed Pharmaceuticals stock market strength indicators, traders can identify Oramed Pharmaceuticals entry and exit signals to maximize returns
Oramed Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oramed Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Oramed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oramed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.011 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.38) | |||
| Sortino Ratio | (0.05) | |||
| Treynor Ratio | 0.0391 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Oramed Stock Analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.